IMPORTANCE OF PHARMACOLOGICAL CONSIDERATIONS IN THE EVALUATION OF NEW TREATMENTS FOR ACUTE SPINAL-CORD INJURY

被引:7
作者
HALL, ED
机构
[1] CNS Research, The Upjohn Company, Kalamazoo, Michigan
关键词
D O I
10.1089/neu.1992.9.173
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
[No abstract available]
引用
收藏
页码:173 / 176
页数:4
相关论文
共 5 条
[1]   EFFECTS OF TREATMENT WITH U-74006F ON NEUROLOGICAL OUTCOME FOLLOWING EXPERIMENTAL SPINAL-CORD INJURY [J].
ANDERSON, DK ;
BRAUGHLER, JM ;
HALL, ED ;
WATERS, TR ;
MCCALL, JM ;
MEANS, ED .
JOURNAL OF NEUROSURGERY, 1988, 69 (04) :562-567
[2]   Effect of Delayed Administration of U74006F (Tirilazad Mesylate) on Recovery of Locomotor Function After Experimental Spinal Cord Injury [J].
Anderson, Douglas K. ;
Hall, Edward D. ;
Braughler, J. Mark ;
McCall, John M. ;
Means, Eugene D. .
JOURNAL OF NEUROTRAUMA, 1991, 8 (03) :187-192
[3]  
HALL E D, 1989, Journal of Neurotrauma, V6, P169, DOI 10.1089/neu.1989.6.169
[4]   THE NEUROPROTECTIVE PHARMACOLOGY OF METHYLPREDNISOLONE [J].
HALL, ED .
JOURNAL OF NEUROSURGERY, 1992, 76 (01) :13-22
[5]  
HALL ED, 1982, SURG NEUROL, V18, P3320